In a Phase 3 obesity trial, patients on the highest dose of the weekly injectable, called survodutide, lost 13% of their weight after 76 weeks, compared with 5% in the placebo group, according to data presented Sunday at the annual meeting of the American Diabetes Association and published in the New England Journal of Medicine
While the injectable form is the most common, some individuals use oral semaglutide
Regular monitoring as recommended by your healthcare provider, including assessment of weight loss progress, side effect management, and overall health status, remains essential throughout Wegovy treatment
Unlike synthetic drugs that force a reaction (and often come with heavy side effects), peptides simply amplify the signals your body is already trying to send
Gourgari E, Wilhelm EE, Hassanzadeh H, Aroda VR, Shoulson I